GlassScriptPhysician profile
Latonya King
NPI 1023579885
$5,059.87
in general payments reported to CMS, 2019-2025
15 companies · $1,472 in 2025
The $1,472 reported for 2025 was more than what 88% of Psychiatric/Mental Health (Nurse Practitioner) providers received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,049 · 2022: $754 · 2023: $850 · 2024: $935 · 2025: $1,472.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,257.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,257.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,513.09 | 2021-2025 | |
| Janssen Pharmaceuticals, INC | $877.02 | 2021-2025 | Spravato, Invega Sustenna |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $766.71 | 2021-2025 | Caplyta |
| Otsuka America Pharmaceutical, INC. | $720.48 | 2023-2025 | Rexulti, Abilify Maintena |
| Neurocrine Biosciences, INC. | $206.87 | 2025 | |
| Corium, LLC | $162.99 | 2024-2025 | Azstarys, Azstarys |
| Sunovion Pharmaceuticals INC. | $146.69 | 2021-2022 | |
| Alkermes, INC. | $122.06 | 2025 | Aristada, Aristada Initio |
| Vanda Pharmaceuticals INC. | $120.98 | 2025 | Fanapt |
| E.R. Squibb & Sons, L.L.C. | $113.85 | 2024 | Cobenfy |
| Axsome Therapeutics, INC. | $109.25 | 2025 | Auvelity |
| Indivior INC. | $90.97 | 2021-2024 | Sublocade |
| Neuronetics, INC. | $54.62 | 2022-2023 | Neurostar Tms Therapy System |
| Lundbeck LLC | $38.12 | 2023-2024 | Rexulti |
| Tris Pharma INC | $16.17 | 2025 | Dyanavel Xr |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Latonya King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.